EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $542,000 | +82.5% | 368,364 | +42.3% | 0.00% | – |
| Q1 2022 | $297,000 | -86.7% | 258,867 | -71.0% | 0.00% | – |
| Q4 2021 | $2,236,000 | +6.4% | 893,724 | +117.6% | 0.00% | – |
| Q3 2021 | $2,102,000 | -36.6% | 410,756 | +3.0% | 0.00% | – |
| Q2 2021 | $3,313,000 | +184.1% | 398,751 | +198.1% | 0.00% | – |
| Q1 2021 | $1,166,000 | -58.0% | 133,783 | -47.7% | 0.00% | – |
| Q4 2020 | $2,778,000 | -6.9% | 255,768 | +2.3% | 0.00% | – |
| Q3 2020 | $2,983,000 | -52.0% | 250,096 | -35.4% | 0.00% | -100.0% |
| Q2 2020 | $6,216,000 | +13.3% | 386,957 | +9.4% | 0.00% | -50.0% |
| Q1 2020 | $5,484,000 | -71.9% | 353,547 | -55.5% | 0.00% | -66.7% |
| Q4 2019 | $19,537,000 | +584.8% | 794,168 | +187.2% | 0.01% | +500.0% |
| Q3 2019 | $2,853,000 | -28.9% | 276,568 | -13.5% | 0.00% | – |
| Q2 2019 | $4,014,000 | +842.3% | 319,738 | +829.5% | 0.00% | – |
| Q1 2019 | $426,000 | -37.4% | 34,400 | -31.5% | 0.00% | – |
| Q2 2018 | $680,000 | +199.6% | 50,200 | +292.2% | 0.00% | – |
| Q1 2018 | $227,000 | -87.9% | 12,800 | -91.4% | 0.00% | – |
| Q4 2017 | $1,876,000 | -31.8% | 149,500 | +3.5% | 0.00% | -100.0% |
| Q3 2017 | $2,751,000 | +27.5% | 144,400 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $2,157,000 | +34.0% | 142,800 | +7.3% | 0.00% | – |
| Q4 2016 | $1,610,000 | +55.3% | 133,073 | +26.3% | 0.00% | – |
| Q3 2016 | $1,037,000 | +321.5% | 105,400 | +585.9% | 0.00% | – |
| Q4 2015 | $246,000 | -94.1% | 15,366 | -95.3% | 0.00% | -100.0% |
| Q3 2015 | $4,185,000 | +135.9% | 325,423 | +340.3% | 0.00% | – |
| Q2 2015 | $1,774,000 | +197.2% | 73,911 | +132.4% | 0.00% | – |
| Q1 2015 | $597,000 | +210.9% | 31,800 | +211.8% | 0.00% | – |
| Q4 2014 | $192,000 | -73.7% | 10,200 | -62.1% | 0.00% | – |
| Q3 2014 | $729,000 | -40.0% | 26,900 | -49.5% | 0.00% | -100.0% |
| Q1 2014 | $1,214,000 | +237.2% | 53,304 | +317.1% | 0.00% | – |
| Q2 2013 | $360,000 | – | 12,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |